Intranasal epinephrine was administered within 1 minute of identifying the reaction or when the patient returned to the ...

Discover a study examining epinephrine for anaphylaxis safety, highlighting cardiovascular risks, correct dosing, and why ...

A new partnership between Thomas Jefferson University and Sempresto, Inc. is positioning a next-generation epinephrine autoinjector to reshape how millions of severe allergy patients ...

Please provide your email address to receive an email when new articles are posted on . Testing included extreme temperatures, submersion in water, and repeated folding. Strips retained potency after ...

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead ...